Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AstraZeneca
Age
45–130
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Breast Cancer has continued to grow after having received treatment with an anti-estrogen hormonal treatment such as tamoxifen or an aromatase inhibitor.
Requiring hormonal treatment.
Postmenopausal women (woman who has stopped having menstrual periods)
You may not be if
Treatment with more than one previous regimen of systemic anticancer therapy other than endocrine therapy for advanced BC.
Treatment with more than one previous regimen of endocrine therapy for advanced BC.
An existing condition that prevents compliance.
Clareo Health | A Clinical Trial to Compare Efficacy and Tolerability of Fulvestrant 250mg, 250mg Plus 250mg Loading Regimen and 500mg
